Of the more than 100 cannabinoids found in marijuana, the cannabinoids most commonly associated with the plant are Tetrahydrocannabinol (THC) and Cannabidiol (CBD). These cannabinoids interact with the Endocannabinoid System (ECS), a system which is known to regulate pain, appetite, mood, memory, immune response, sleep, and cellular level life cycles. THC will bind directly to CB1 and CB2 receptors in the ECS, with a higher affinity for CB1 receptors, while CBD acts as an indirect antagonist of cannabinoid receptor agonists, and even binds with non-cannabinoid receptors.
Many medical marijuana patients opt for CBD in their routines due to the fact it does not produce psychoactive or euphoric effects like THC. In fact, for those who desire the therapeutic relief that THC offers, CBD can actually buffer against its psychoactive effects, so that the patient can experience symptom relief without unwanted side effects. THC may produce side effects like memory impairment, lowered reaction time, increased heart rate, coordination problems, dry mouth, and red eye. One can’t overdose from THC, but adolescence who consume high amounts of THC may experience long-term psychiatric side effects. CBD, on the other hand, is considered all around well-tolerated and safe, and the only potential mild side effects include dry mouth, light-headedness, and drowsiness. Producers can produce medical marijuana strains with different cannabinoid compositions tailored to the specific needs of patients. That said, many marijuana strains, especially in today’s world of high potency marijuana, contain higher amounts of THC while hemp contains very little THC and strong concentrations of CBD.
This information has been brought to you by Medical Marijuana Inc. and approved by our Chief Medical Officer.